Perindopril effects on circadian heart rate variability in patients with coronary heart disease and stable angina
Abstract
Aim. To study the effects of ACE inhibitor perindopril on circadian dynamic of heart rate variability (HRV) in patients with coronary heart disease (CHD) and stable effort angina.
Material and methods. The study included 68 patients with stable effort angina, without myocardial infarction in anamnesis, as well as 30 controls. Circadian HRV was assessed by Holter monitoring method, during isosorbide dinitrate and aspirin therapy, and 31 days after adding perindopril (4-8 mg/d).
Results. At baseline, temporal and spectral HRV parameters were decreased in CHD patients with stable angina, improving during perindopril therapy (4-8 mg/d). Positive dynamics was maximal for parasympathetic activity markers. Perindopril therapy also reduced ventricular extrasystole number in CHD patients.
Conclusion. Perindopril (4-8 mg/d) improved circadian BP dynamics in CHD patients with stable effort angina, especially in individuals with advanced functional classes. Perindopril also demonstrated antiarrhythmic effect.
About the Authors
N. A. Shardanov
Medico-Ecological Research Center, Russian Federation State Research Center Branch, Institute of Medico-Biological Problems, Russian Academy of Sciences, Nal’chik
Russian Federation
Russian Federation
E. K. Arsagova
Medico-Ecological Research Center, Russian Federation State Research Center Branch, Institute of Medico-Biological Problems, Russian Academy of Sciences, Nal’chik
Russian Federation
Russian Federation
L. M. Batyrbekova
Medico-Ecological Research Center, Russian Federation State Research Center Branch, Institute of Medico-Biological Problems, Russian Academy of Sciences, Nal’chik
Russian Federation
Russian Federation
M. Kh. Kurdanova
Medico-Ecological Research Center, Russian Federation State Research Center Branch, Institute of Medico-Biological Problems, Russian Academy of Sciences, Nal’chik
Russian Federation
Russian Federation
Kh. A. Kurdanov
Medico-Ecological Research Center, Russian Federation State Research Center Branch, Institute of Medico-Biological Problems, Russian Academy of Sciences, Nal’chik
Russian Federation
Russian Federation
References
1. Heart rate variability. Standard of measurement, physiological interpretation and clinical use. Task Force of the European society of cardiology and the North American society of pacing end electrophysiology (membership of the Task Force listed in the appendix). Eur Heart J 1996; 17: 354-81.
2. The HOPE Study Investigators. Effect of angiotensin-converting enzyme inhibitor, ramiprili, on death. From cardiovascular causes, myocardial infarction, and stroke or transient ischemic attack. Lancet 2001; 358: 1033-41.
3. The EURopean trial. On reduction of cardiac events with Perindopril in stable coronary artery disease. Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients stable coronary artery disease: randomized, double-blind, placebo-controlled, multicenter trial (The EUROPA study). Lancet 2003; 362: 782-8.
4. Malik M, Farrell J, Cannam AJ. Heart rate variability in relation to prognosis after myokardial infarction: selection of optimal processing techniques. Eur Heart J 1989; 10: 1060-74.
5. Binkley PF, Haas EJ, Starling RC, et al. Sustained augmentation of parasympathetic tone with angiotensin converting enzyme inhibitor with congestive heart failure. JACC 1993; 21: 655-61.
6. Derad I, Otterbein A, Molle M, et al. The angiotensin converting enzyme inhibitors fosinopril end enalapril differ in ther central nervous effects in humans. J Hypertens 1996; 14(11): 1309-5.
7. Dreifus LS, Agearwal JB, Botvinick EH, et al. Heart rate variability for risk stratification of life-threatening arrhythmias. JACC 1993; 22: 948-50.
8. Задионченко В.С., Мартынова Л.Н., Тимофеева Р.Ю. Анисина Т.Т. Вариабельность сердечного ритма в оценке прогрессирования сердечной недостаточноcти и эффективности терапии ингибиторами ангиотензин-превращающего фермента. Серд недоcтат 2001; 2(5): 45-9.
9. Карпов Ю.А. Клинические последствия ингибирования тканевого ангиотензин-превращающего фермента: целесообразность при стабильной ишемической болезни сердца. Кардиология 2002; 6: 86-91.
Review
For citations:
Shardanov N.A., Arsagova E.K., Batyrbekova L.M., Kurdanova M.Kh., Kurdanov Kh.A. Perindopril effects on circadian heart rate variability in patients with coronary heart disease and stable angina. Cardiovascular Therapy and Prevention. 2007;6(4):37-40. (In Russ.)
Views:
5330
Email this article 
